Relevant mechanistic studies have shown that DDB2 decreases NF-κB activity and the expression of matrix metalloproteinase 9 (MMP9) by upregulating IκBα gene expression, limiting cancer cell invasiveness [83]. Here, MMP9 is linked to cancer.